Global biotechnology leader CSL Limited (ASX: CSL; USOTC:CSLLY) and Vifor Pharma Ltd (SIX:VIFN; ISIN:CH0364749348), a global specialty pharmaceutical company with leadership in iron deficiency, ...

Rezolv Energy, backed by Actis, has secured project finance facilities of €331m ($385m) for the construction of the second phase of its VIFOR wind farm project in Buzău County, Romania. The second ...

CSL Limited (ASX: CSL; USOTC:CSLLY) is pleased to announce it has now received all necessary regulatory clearances for the acquisition of Vifor Pharma AG (Vifor) announced on 14 December 2021. CSL has ...

Call it a bad day for Teva and a good one for CSL Vifor. A Delaware district court ruled that a proposed Teva generic of CSL Vifor’s chronic kidney (CKD) drug Velphoro infringes an existing patent.

Vifor Pharma Group net sales increased by 2.8% to CHF 1,754.2 million compared to the previous year, or 4.0% at CER, as patient access recovered in line with easing COVID-19 restrictions in key ...

ST. GALLEN, Switzerland & UNIONDALE, NY--(BUSINESS WIRE)--Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma and Angion Biomedica Corp. (NASDAQ: ANGN) today announced that the ...

SAN DIEGO & ST. GALLEN, Switzerland--(BUSINESS WIRE)-- CSL Vifor and Travere Therapeutics, Inc. (TVTX), support the recent publication of the updated clinical practice guidelines for the treatment of ...

SAN DIEGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) and CSL Vifor today announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the ...